Studies on Lowe syndrome have suggested that OCRL may act through regulation of TRPV4 (Luo et al., 2014; Jing et al., 2024), and a novel disease-causing OCRL allele prevents TRPV4-mediated calcium signaling. The gene discussed is OCRL; the disease is oculocerebrorenal syndrome.